The heart behind the strategy: J&J leaders on why social impact isn’t optional

Johnson & Johnson’s senior leaders explore why social impact isn’t just an organisational strategy, but a personal calling. In this Health Industry Hub podcast, Joana De Castro, Managing Director of J&J Innovative Medicine ANZ, and Sarah Najdek, Managing Director of J&J MedTech ANZ, reveal how purpose-driven leadership is shaping the way the company approaches its mission in healthcare.

From ranking among the top five in the global Access to Medicine Index to initiatives that reach the most vulnerable communities locally, Johnson & Johnson’s work sits at the intersection of innovation, health equity, and social responsibility.

Yet, meaningful change doesn’t come without its barriers. The leaders unpack the complexities of driving corporate social impact – from addressing internal hurdles to navigating the shifting expectations around social impact reporting.

For all the structure and strategy, this conversation keeps circling back to something far more human – the personal passion that drives leaders to push boundaries in the first place. For De Castro and Najdek, the “why” behind the work is as compelling as the initiatives themselves.

In reimagining healthcare across the entire patient journey, Health Industry Hub^TM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry Hub^TM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.